首页 | 本学科首页   官方微博 | 高级检索  
   检索      


EUCAST and CLSI: How to Assess in Vitro Susceptibility and Clinical Resistance
Authors:Ana Alastruey-Izquierdo  Manuel Cuenca-Estrella
Institution:1.Mycology Reference Laboratory, National Center for Microbiology,Instituto de Salud Carlos III,Madrid,Spain;2.Servicio de Micología, Centro Nacional de Microbiología,Instituto de Salud Carlos III,Madrid,Spain
Abstract:There are two different approved reference procedures based on microdilution techniques for antifungal susceptibility testing (AFST) of fungal species, the CLSI and the EUCAST procedures. Although there have always been some methodological differences between them, AFST results are comparable. In addition, current breakpoints values of antifungal compounds to interpret AFST results set by both institutions are very similar with some exceptions. Experts advised AFST should be done with validated commercial techniques for a routine daily practice and discrepant results should be confirmed by reference procedures particularly for isolates with borderline/resistant MIC values. Reference methods by EUCAST and CLSI should be also used in periodical epidemiological studies, to evaluate new antifungal agents, new methods of AFST and to know the susceptibility profile of rare and emerging fungal species.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号